New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Aclarion, Inc.

Contributing Author

Recent Articles by Aclarion, Inc.

25 min	Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst ACON GlobeNewswire
Oct-13	Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference ACON +12.71% GlobeNewswire
Oct-07	Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH ACON GlobeNewswire
Oct-01	Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers ACON GlobeNewswire
Sep-25	First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial ACON GlobeNewswire
Sep-03	Aclarion Appoints Greg Gould as Chief Financial Officer ACON GlobeNewswire
Aug-05	Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts ACON GlobeNewswire
Jul-07	Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders ACON GlobeNewswire
Jun-25	First Patient Enrolled in Aclarion's Groundbreaking CLARITY Trial ACON GlobeNewswire
Jun-24	Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum ACON GlobeNewswire
Jun-10	Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site ACON GlobeNewswire
May-20	Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site ACON GlobeNewswire
May-12	Aclarion Announces Texas Back Institute as New CLARITY Trial Site ACON GlobeNewswire
May-05	Aclarion Welcomes Advocate Health as CLARITY Trial Site ACON GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.